首页 | 本学科首页   官方微博 | 高级检索  
     

EDOP方案治疗复发难治性恶性淋巴瘤45例分析
引用本文:鲍慧铮,程颖. EDOP方案治疗复发难治性恶性淋巴瘤45例分析[J]. 吉林医学, 2006, 27(1): 47-48
作者姓名:鲍慧铮  程颖
作者单位:吉林省肿瘤医院,吉林长春130012
摘    要:目的:观察EDOP方案治疗复发难治性恶性淋巴瘤的疗效和毒副作用。方法:对45例复发难治性恶性淋巴瘤患者采用EDOP联合化疗方案进行治疗。结果:EDOP联合化疗方案有效率为(CR+PR)71.1%,完全缓解率(CR)为33.3%,部分缓解(PR)37.8%。主要不良反应为骨髓抑制和胃肠道反应。结论:EDOP方案治疗难治性或复发性恶性淋巴瘤有效率高,毒副反应低,值得进一步研究和推广。

关 键 词:EDOP方案  恶性淋巴瘤  复发
文章编号:1004-0412(2006)01-47-02
收稿时间:2005-10-02
修稿时间:2005-10-02

Treatment of refractory or relapsing malignant lymphoma with EDOP regimens:a report of 45 cases
BAO Hui-zheng,CHENG Ying. Treatment of refractory or relapsing malignant lymphoma with EDOP regimens:a report of 45 cases[J]. Jilin Medical Journal, 2006, 27(1): 47-48
Authors:BAO Hui-zheng  CHENG Ying
Affiliation:Jilin Province Tumor Hospital,Changchun 130012,China
Abstract:Objective To evaluate the effects and side-effects of EDOP regimens of refractory or relapsing malignant lymphoma. Method 45 patients with refractory or relapsing malignant lymphoma were treated with EDOP regimens. Results The overall response rate was 71.1%, the rate of complete remission was 33.3%, the rate of partial remission was 37.8%.Main toxicities were neutropem and gastrointestinal side effects. Conclusion EDOP regimen has high effects and is safe in treatment of refractory or relapsing malignant lymphoma.
Keywords:EDOP regimens   malignant lymphoma
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号